AstridBio Technologies Ltd. along with its partner TS labor Ltd. successfully completed a Market-driven research, development, and innovation project entitled Development of reagent products based on glycosylation patterns and implementation of diagnostic developments
AstridBio Technologies Ltd. along with its partner TS labor Ltd. successfully completed a Market-driven research, development, and innovation project entitled Development of reagent products based on glycosylation patterns and implementation of diagnostic developments
AstridBio was granted a Research Development and Innovation Support of National Research, Development and Innovation Office of Hungary
The project will create a technological process and use it to develop three high-value natural soil improvement products (potting soil; liquid manure; and inoculated duck manure pellets). Large-scale duck farming (25-27 million animals), produces at least 100-130 thousand tons of manure in Hungary alone every year.
ASTRIDBIO TECHNOLOGIES AND TS LABOR KFT GRANTED BY NATIONAL RESEARCH, DEVELOPMENT AND INNOVATION OFFICE FOR THE DEVELOPMENT OF NEW TYPES OF REAGENTS KITS
The research project “Development of reagent products based on glycosylation patterns and implementation of diagnostic developments” officially started on 1st February 2020 with a set duration of 36 months. The project aims to develop diagnostic methods that can detect the changes in the glycosylation of certain serum proteins, especially in the early markers of chronic liver diseases and the pathophysiological processes of the liver.
AstridBio ’s scientific poster on German Mass Cytometry User Forum
AstridBio Technologies’ scientific poster on 3rd German Mass Cytometry User Forum in Berlin The 3rd German Mass Cytometry User Forum held on January 23rd –
AstridBio Technologies participated in work on Single Cell Mass Cytometry of Non-Small Cell Lung Cancer published in Cells
Single cell genomics and proteomics with the combination of innovative three-dimensional (3D) cell culture techniques can open new avenues toward the understanding of intra-tumor heterogeneity.
Presenting PrECISE: New Hope for Prostate Cancer
Using artificial intelligence PrECISE helps integrate patients genetic profile with the results of various health reports, scientific publications, statistics, and genomic data in order to